Abstract
Background: Fluorescent laparoscopic imaging of primary colorectal tumours and lymph node metastases would potentially facilitate intra-operative stratification of surgical resections and improve patient outcomes. Nanoparticulate platforms offer many advantages in terms of intra-operative imaging and biosensing for diagnostic purposes. Nanoparticles can be loaded with diverse reagents and then addressed to the correct tissue provided a specific biomarker molecule exists to which an antibody or Affimer (artificial binding protein) can be developed. We aimed to develop a fluorescent silica nanoparticles targeted against colorectal cancer (CRC) using an anti-carcinoembryonic antigen (CEA) Affimer (Aff).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
